Brief: Enorama Pharma Q1 Operating Loss Narrows To SEK 10.9 Mln
20/05/2026 08:11
May 20 (Reuters) - Enorama Pharma AB ERMA.ST: Q1 NET SALES AMOUNTED TO -109 KSEK Q1 OPERATING RESULT AMOUNTED TO -10,877 KSEK Source text: ID:nWkr97Bm0p Further company coverage: ERMA.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO